Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 2,468,000 | 3,324,000 | 2,918,000 | 0 | 2,017,000 |
| Total expenses | 3,302,000 | 2,580,000 | 2,342,000 | N/A | 2,849,000 |
| Operating Income | -834,000 | 744,000 | 576,000 | N/A | -832,000 |
| Interest Expense | 415,000 | 427,000 | 384,000 | 0 | 389,000 |
| Other Income | -106,000 | -39,000 | 53,000 | 0 | 28,000 |
| Pre-tax Income | -1,355,000 | 278,000 | 245,000 | 0 | -1,193,000 |
| Income Tax | -315,000 | 90,000 | 140,000 | N/A | -393,000 |
| Net Income Continuous | -1,040,000 | 188,000 | 105,000 | N/A | -800,000 |
| Net Income Discontinuous | -222,000 | -17,000 | 166,000 | N/A | 895,000 |
| Minority Interests | -15,000 | -3,000 | 7,000 | N/A | N/A |
| Net Income | $-1,247,000 | $174,000 | $264,000 | $N/A | $90,000 |
| EPS Basic Continuous Ops | -6.25 | 1.14 | 0.13 | N/A | -2.12 |
| EPS Basic Discontinuous Ops | -1.35 | -0.10 | 0.22 | N/A | 2.31 |
| EPS Basic Total Ops | -7.60 | 1.04 | 0.35 | N/A | 0.18 |
| EPS Diluted Continuous Ops | -6.25 | 1.14 | 0.13 | N/A | -2.12 |
| EPS Diluted Discontinuous Ops | -1.35 | -0.10 | 0.22 | N/A | 2.31 |
| EPS Diluted Total Ops | -7.60 | 1.04 | 0.35 | N/A | 0.18 |
| EBITDA(a) | $-42,000 | $1,120,000 | $909,000 | $N/A | $-554,000 |